The ISIDORe project (Integrated Services For Infectious Disease Outbreak Research) assembles the largest and most diverse research and service-providing instrument to study infectious diseases in Europe, with expertise from structural biology to clinical trials. By giving scientists access to the whole extent of our state-of-the-art facilities, cutting-edge services, advanced equipment and expertise, in an integrated way and with a common goal, we will accelerate the generation of new knowledge and intervention tools to enhance Europe’s capacity for controlling (re)emerging and epidemic infectious diseases, starting with the COVID-19 pandemic. ISIDORe supports scientists and their research on epidemic- and pandemic-prone pathogens, the development of medical countermeasures, with the aim of increasing resilience in the face of epidemics in Europe and globally.
Outcomes of the project are:
- Advance research on epidemic-prone diseases
- Increase epidemic preparedness and responsiveness
- Support the development of medical countermeasures against epidemic-prone pathogens
- Share research data emerging from access provision activities according to FAIR principles ("Findable, Accessible, Interoperable, and Re-usable")
ISIDORe is a unique European integrated large-scale research infrastructure capacity for conducting research on any epidemic-prone pathogen, including SARS-CoV-2. It will be a powerful instrument at the disposal of the EU, and will impact its capacity to identify, characterise and mitigate the effects of any epidemic-prone pathogens.
ISIDORe aims to enable ground-breaking discoveries and the development of new medical countermeasures with high impact on health security and society.
For more information see https://isidore-project.eu
Involved INNT scientists:
Dr. Markus Keller
Dr. Martin Eiden
PD Dr. Anne Balkema-Buschmann
Dr. Sandra Diederich
Dr. Balal Sadeghi
Dr. Kerstin Fischer
Dr. Christine Fast
Prof. Dr. Martin H. Groschup
